• Vaccines, three million administrations in Italy

  • Vaccines, European Commission: "Bilateral purchases only if extra EU strategy"

  • Von der Leyen: "Underestimated difficulty of mass production of vaccines. Science has overtaken industry"

Share

February 15, 2021 "On Wednesday" the European Commission "will present" a "proposal to accelerate the authorization of vaccines adapted to the new variants".

The spokesperson of the EU Commission, Vivian Loonela, said this.

"There will be no need to start the authorization process all over again - said the official - when it comes to adapting the vaccine for the variants, the authorization procedure will be modified with a new system to speed up approval while maintaining the levels of safety".



"We will build on what is already happening with the flu vaccines - added Loonela -. Ema is already updating the minimum requirements for the changes, so we will speed up the authorization procedure".

The European Medicines Agency asked vaccine manufacturers on February 10 to submit data on protection against the new variants.

The data, the Agency had clarified, are used to define the requirements for approving the adaptations of existing vaccines to coronavirus mutations.   



"We also invite manufacturers to adapt their vaccines as soon as possible and provide Ema with the necessary information", concluded the official.

"We are doing our utmost together with pharmaceutical companies to increase production in Europe on already approved vaccines - added the other European Commission spokesperson, Dana Spinant - and then we are turning our attention to the variants on which the response must be adequate in terms of speed and scale ".